Owing to its aggressive biological behavior, the lack of specific targets, and the strong
therapeutic resistance of triple negative breast cancer (TNBC), current therapeutic strategies …

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with
ineffective treatment and poor prognosis. It is in great demand to develop a novel theranostic …

In the present work, an iridium (Ir) complex loaded theranostic nanoplatform was designed
for high-efficiency triple-negative breast cancer (TNBC) therapy. For this purpose, the Ir …

A multifunctional nanoplatform with core–shell structure was constructed in one-pot for the
synergistic photothermal, photodynamic, and chemotherapy against breast cancer. In the …

Triple-negative breast cancer (TNBC) is a type of highly aggressive cancer that is hard to be
cured by the commonly used chemotherapy, mainly due to the lack of effective tumor …

Background Breast cancer has become the most common cancer in women. Compare with
other subtypes of breast cancer, triple-negative breast cancer (TNBC) is more likely to …

Metastasis is one of the main causes of failure in the treatment of triple-negative breast
cancer (TNBC). Immunotherapy brings hope and opportunity to solve this challenge, while …

Triple negative breast cancer (TNBC) is highly malignant and prone to recurrence and
metastasis. Patients with TNBC usually have poor prognosis. Hence, it is urgent to develop …

Multi-modal imaging-guided cancer photothermal therapy (PTT) with advanced theranostic
nanoagents can efficiently improve therapeutic efficacy and reduce treatment side effects …

Despite immunotherapy having revolutionized cancer therapy, the efficacy of
immunotherapy in triple-negative breast cancer (TNBC) is seriously restricted due to the …